White House Keeping Low Profile As Hunt For Healy's Successor At NIH Appears To Be Reaching Final Stage

Judith Rodin of Yale and UC-San Francisco's Harold Varmus are said to be strong contenders for the agency position Author: FRANKLIN HOKE, pp. 1, 3, 4 Sources close to the search for Bernadine Healy's successor as director of the National Institutes of Health say the list of candidates is down to three individuals, with a decision from the White House considered imminent. In the running at press time were Harold Varmus, a Nobel Prize- winning molecular biologist at the University of C

Written byFranklin Hoke
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Judith Rodin of Yale and UC-San Francisco's Harold Varmus are said to be strong contenders for the agency position
Author: FRANKLIN HOKE, pp. 1, 3, 4

Sources close to the search for Bernadine Healy's successor as director of the National Institutes of Health say the list of candidates is down to three individuals, with a decision from the White House considered imminent.

In the running at press time were Harold Varmus, a Nobel Prize- winning molecular biologist at the University of California, San Francisco, School of Medicine, known for his work on oncogenes, and Judith Rodin, the provost of Yale University, New Haven, Conn. The identity of the third candidate could not be confirmed through sources.

Healy, who was not asked to stay on at her post by new President Bill Clinton early this year, announced in February that she would step down as NIH director on June 30. Ruth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies